These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19076696)

  • 21. A unified cell biological perspective on axon-myelin injury.
    Simons M; Misgeld T; Kerschensteiner M
    J Cell Biol; 2014 Aug; 206(3):335-45. PubMed ID: 25092654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial Dynamics in Physiology and Pathology of Myelinated Axons.
    Sui Y; Nguyen HB; Thai TQ; Ikenaka K; Ohno N
    Adv Exp Med Biol; 2019; 1190():145-163. PubMed ID: 31760643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.
    Campbell G; Mahad DJ
    FEBS Lett; 2018 Apr; 592(7):1113-1121. PubMed ID: 29453889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
    Ohno N; Chiang H; Mahad DJ; Kidd GJ; Liu L; Ransohoff RM; Sheng ZH; Komuro H; Trapp BD
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9953-8. PubMed ID: 24958879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 26. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.
    Cambron M; D'Haeseleer M; Laureys G; Clinckers R; Debruyne J; De Keyser J
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):413-24. PubMed ID: 22214904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
    Dutta R; Chang A; Doud MK; Kidd GJ; Ribaudo MV; Young EA; Fox RJ; Staugaitis SM; Trapp BD
    Ann Neurol; 2011 Mar; 69(3):445-54. PubMed ID: 21446020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure.
    Bando Y
    Adv Exp Med Biol; 2019; 1190():257-264. PubMed ID: 31760649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
    Su KG; Banker G; Bourdette D; Forte M
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):411-7. PubMed ID: 19664372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of mitochondria in axonal degeneration and tissue repair in MS.
    van Horssen J; Witte ME; Ciccarelli O
    Mult Scler; 2012 Aug; 18(8):1058-67. PubMed ID: 22723572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination.
    Smith CM; Cooksey E; Duncan ID
    J Neurosci; 2013 Feb; 33(6):2718-27. PubMed ID: 23392698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
    Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
    Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter.
    Luchicchi A; Hart B; Frigerio I; van Dam AM; Perna L; Offerhaus HL; Stys PK; Schenk GJ; Geurts JJG
    Ann Neurol; 2021 Apr; 89(4):711-725. PubMed ID: 33410190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis.
    Ure DR; Rodriguez M
    Neuroscience; 2002; 111(2):399-411. PubMed ID: 11983325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.